https://doi.org/10.1158/1078-0432.ccr-11-2295
A
Annette M. Lim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
2.9K
Citations
20
h-index
33
i10-index
Annette M. Lim is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Head and Neck Cancer Studies & Nonmelanoma Skin Cancer Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 20, co-authored 85 publications.
ORCID: 0000-0002-0777-2279Papers by this author
worksPrognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
2011 · Clinical Cancer Research · 52 citations
A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma
2020 · Scientific Reports · 49 citations
https://doi.org/10.1038/s41598-020-63180-8
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma
2025 · New England Journal of Medicine · 42 citations
https://doi.org/10.1056/nejmoa2502449
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome
2014 · Clinical Epigenetics · 21 citations
https://doi.org/10.1186/1868-7083-6-22
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
2021 · Cancer Imaging · 17 citations
https://doi.org/10.1186/s40644-021-00426-2
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study
2024 · The Medical Journal of Australia · 16 citations
https://doi.org/10.5694/mja2.52199
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat